BioNTech SE Ownership | Who Owns BioNTech SE?
BioNTech SE Ownership Summary
BioNTech SE is owned by 8.32% institutional investors, 61.84% insiders, and 29.84% retail investors. Baillie gifford is the largest institutional shareholder, holding 3.26% of BNTX shares. Franklin All Country World ex US Equity is the top mutual fund, with 8.32% of its assets in BioNTech SE shares.
BNTX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | BioNTech SE | 8.32% | 61.84% | 29.84% |
| Sector | Healthcare Stocks | 42.54% | 10.83% | 46.63% |
| Industry | Biotech Stocks | 45.22% | 10.75% | 44.04% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Baillie gifford | 7.88M | 3.26% | $777.06B |
| Fmr | 5.45M | 2.26% | $537.82M |
| T. rowe price investment management | 4.83M | 2.00% | $476.69M |
| Flossbach von storch | 4.23M | 1.75% | $417.17M |
| Primecap management co/ca/ | 3.87M | 1.60% | $381.73M |
| Dodge & cox | 3.65M | 1.51% | $359.68M |
| Blackrock | 1.90M | 0.79% | $152.32M |
| Pfizer | 1.66M | 0.69% | $163.55M |
| Temasek (private) | 1.51M | 0.62% | $148.52M |
| Capital investors | 1.14M | 0.47% | $111.94M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Pfizer | 1.66M | 37.39% | $163.55M |
| Bill & melinda gates foundation | 148.67K | 19.99% | $11.95M |
| Logos global management lp | 300.00K | 4.00% | $34.19M |
| Krensavage asset management | 79.37K | 3.33% | $7.83M |
| Crocodile capital partners gmbh | 29.59K | 2.38% | $2.92M |
| Flossbach von storch | 4.23M | 1.64% | $417.17M |
| Long focus capital management | 397.65K | 1.30% | $39.22M |
| Sectoral asset management | 17.66K | 1.07% | $1.74M |
| Tang capital management | 270.00K | 1.02% | $26.63M |
| Baader bank aktiengesellschaft | 152.87K | 0.97% | $14.93M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Dodge & cox | 3.65M | 0.19% | 2.77M |
| T. rowe price investment management | 4.83M | 0.29% | 1.24M |
| Ubs group | 607.44K | 0.01% | 349.15K |
| Logos global management lp | 300.00K | 4.00% | 300.00K |
| Victory capital management | 413.69K | 0.02% | 203.70K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 5.45M | 0.03% | -2.71M |
| Pfizer | 1.66M | 37.39% | -2.00M |
| Capital world investors | - | - | -955.98K |
| Viking global investors lp | - | - | -879.97K |
| Invesco | 74.16K | 0.00% | -606.94K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Logos global management lp | 300.00K | 4.00% | 300.00K | $34.19M |
| Ghisallo capital management | 125.00K | 0.40% | 125.00K | $12.33M |
| Hrt financial lp | 36.92K | 0.01% | 36.92K | $3.64M |
| Quadrature capital | 22.20K | 0.03% | 22.20K | $2.19M |
| Xtx topco | 14.80K | 0.08% | 14.80K | $1.46M |
Sold Out
| Holder | Change |
|---|---|
| Harbor investment advisory | -1.00 |
| Clear street markets | -1.00 |
| Cornerstone planning group | -1.00 |
| Halbert hargrove global advisors | -1.00 |
| Signaturefd | -1.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 105 | -62.09% | 20,093,114 | -62.09% | 8 | 1.71% | 36 | -70.97% | 37 | -51.32% |
| Jun 30, 2025 | 283 | -8.41% | 53,736,135 | 4.22% | 22 | 4.86% | 122 | 11.93% | 80 | -22.33% |
| Mar 31, 2025 | 310 | -8.55% | 51,726,357 | 1.91% | 21 | 4.80% | 108 | -28.95% | 105 | 23.53% |
| Dec 31, 2024 | 329 | -2.37% | 50,653,251 | 14.51% | 21 | 6.21% | 146 | -7.59% | 84 | -4.55% |
| Sep 30, 2024 | 334 | 7.40% | 44,218,941 | 7.90% | 18 | 6.35% | 155 | 31.36% | 88 | -12.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Franklin All Country World ex US Equity | 20.00M | 8.32% | 20.00M |
| FvS SICAV Multiple Opportunities F | 2.53M | 1.05% | - |
| Vanguard Capital Opportunity Inv | 2.22M | 0.92% | 54.15K |
| Harding Loevner International Eq Instl | 1.29M | 0.54% | -561.45K |
| FvS Multiple Opportunities II I | 1.12M | 0.47% | - |
| T. Rowe Price US Mid-Cap Growth Equity | 1.02M | 0.43% | 1.02M |
| T. Rowe Price Mid-Cap Growth | 1.02M | 0.43% | -1.90K |
| PRIMECAP Odyssey Aggressive Growth | 975.66K | 0.41% | -68.70K |
| NYLI Merger Arbitrage ETF | 910.52K | 0.38% | - |
| iShares Biotechnology ETF | 893.17K | 0.37% | - |
BNTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools